Coagulopathy caused by intrauterine dextran.
McPhedran
P
P
Seifer
D B
DB
Clyne
L P
LP
Ingbar
D
D
D000042:Absorption; D000328:Adult; D001779:Blood Coagulation Factors / Q000032:analysis; D003911:Dextrans / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D015907:Hysteroscopy; D007247:Infertility, Female / Q000601:surgery; D007889:Leiomyoma / Q000601:surgery; D011183:Postoperative Complications / Q000139:chemically induced*; D011654:Pulmonary Edema / Q000139:chemically induced; D014592:Uterine Hemorrhage / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000601:surgery; D014599:Uterus
D001779:Blood Coagulation Factors; D003911:Dextrans